Skip to main content

Table 1 Baseline characteristics of participants (n = 2417)

From: Association of serum transaminases with short- and long-term outcomes in patients with ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention

Characteristic

N (%) or mean ± SD

Demographic data

 Age (year)

59.5 ± 11.1

 Male, n (%)

1748 (72)

 Living in the city

11,148 (48)

 Hospital days

7.2 ± 3.8

Medical history (n)

 Dyslipidemia

931 (38)

 Diabetes mellitus

545 (23)

 Hypertension

1088 (45)

 Myocardial disease

160 (7)

 Previous myocardial infarction

24 (1)

 Arrhythmias

492 (20)

 Previous stroke

75 (3)

 Malignancies

6 (0.2)

 Peripheral vascular disease

24 (1)

 COPD

30 (1)

Infarct location by ECG

 Inferior

1189 (49)

 Anterior

1172 (48)

 Lateral

56 (2)

 Killip classification

 Cardiogenic shock

101 (4)

 Noncardiogenic shock

2316 (96)

Laboratory data

 K+ (mmol/L)

3.9 ± 0.5

 Creatinine (mmol/L)

75.3 ± 29.8

 Na+ (mmol/L)

139.4 ± 4.1

 Total cholesterol (mmol/L)

4.5 ± 1.0

 HDL-C (mmol/L)

1.1 ± 0.3

 LDL-C (mmol/L)

2.8 ± 0.9

 Triglycerides (mmol/L)

1.7 ± 1.2

 Glucose (mmol/L)

7.1 ± 3.1

 ALT (unit/L)

55.5 ± 108.3

 AST (unit/L)

165.3 ± 283.1

 ALP (unit/L)

72.4 ± 24.4

 GGT (unit/L)

47.4 ± 69.4

 Cardiac troponin I (ng/mL)

20.9 ± 60.9

 Creatine kinase MB (ng/ml)

38.3 ± 75.9

 NT-proBNP (pg/mL)

1829.9 ± 6019.6

  1. SD standard deviation, COPD chronic obstructive pulmonary disease, ECG electrocardiographic, HDL-C high-density lipoprotein cholesterol, LDL-C low-density lipoprotein cholesterol, ALT alanine aminotransferase, AST aspartate aminotransferase, ALP Alkaline phosphatase, GGT ɤ-glutamyl transpeptidase, NT-proBNP N-terminal pro-brain natriuretic peptide